Inactive Instrument

Quotes GENFIT Euronext Paris

Stocks

End-of-day quote Euronext Paris
- ^PTS	-

07-03	Genfit soars on news of U.S. reimbursement for a product
07-03	Genfit's Liver Disease Blood Test Approved for US Medicare Reimbursement	MT

Stock exchange

Euronext Paris GNFT - PTS - 0 PTS

Markets		Price	Change	Volumes
Euronext Paris	GNFT	14.14EUR	-1.67%	3.74M €
CBOE	GNFTp	14.14EUR	-1.53%	682K €
Börse Stuttgart	XUP	14.00EUR	-1.82%	63.41K €
Tradegate	XUP	14.00EUR	-2.51%	3.23K €
Xetra	XUP	14.08EUR	-1.81%	2.77K €
Deutsche Boerse AG	XUP	14.30EUR	-1.11%	0 €
London S.E.	0QT6	14.52EUR	-.--%	0 €
CBOE	0QT6	14.29EUR	-.--%	0 €
Boerse Muenchen	XUP	14.08EUR	-2.09%	0 €

Market Cap ($$$)

718,615,585

Market Cap (USD)

834,801,353

Net sales (EUR)

71,115,000

Net sales (USD)

82,612,873

Free-Float

86.89 %

Free-Float capitalization ($$$)

624,572,045

Free-Float capitalization (USD)

725,552,853

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
GENFIT	-	0.00%	-	-	835M
LONZA GROUP AG	-1.23%	-1.91%	+0.98%	+17.94%	50.47B
REVOLUTION MEDICINES, INC.	-1.11%	-2.84%	+420.04%	+505.15%	44.56B
IQVIA HOLDINGS INC.	-0.21%	+0.53%	+36.88%	+16.32%	43.08B
BEONE MEDICINES AG	-1.95%	-3.33%	+8.29%	+73.25%	41.7B
CELLTRION, INC.	-0.94%	-1.77%	+18.34%	+46.84%	33.21B
MEDPACE HOLDINGS, INC.	-1.11%	-4.20%	+25.49%	+119.78%	16.77B
ASCENDIS PHARMA A/S	+6.10%	+4.40%	-	-	16.28B
EUROFINS SCIENTIFIC SE	+0.25%	-0.41%	+11.91%	+29.03%	14.58B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-1.12%	-2.35%	+76.50%	+37.47%	13.92B
Average	-0.15%	-1.24%	+74.80%	+105.72%	27.54B
Weighted average by Cap.	-0.60%	-1.05%	+88.95%	+122.66%